University Hospital Augsburg, Augsburg.
University hospital Leipzig, Germany.
Curr Opin Obstet Gynecol. 2023 Feb 1;35(1):67-72. doi: 10.1097/GCO.0000000000000835.
In recent years, the therapy of breast carcinoma has evolved at a rapid pace. Therapies from metastasis are pushing into the (neo)adjuvant treatment of breast carcinoma at ever shorter intervals.
Biomarker-based therapeutic approaches became more and more en vogue to guide (neo)adjuvant endocrine therapy and chemotherapy.
This article reviews recent data developments in early breast cancer (EBC) and current recommendations in diagnosis and therapy.
近年来,乳腺癌的治疗发展迅速。转移性治疗方案正以越来越短的间隔推进至乳腺癌的(新)辅助治疗。
基于生物标志物的治疗方法越来越流行,以指导(新)辅助内分泌治疗和化疗。
本文回顾了早期乳腺癌(EBC)的最新数据进展和目前的诊断及治疗建议。